Karamedica, INC
Karamedica develops decontamination processes and medical devices using biopolymer-based products, particularly chitosan sourced from crustacean shells. The company's core technology is non-thermal atmospheric pressure nitrogen plasma, which it uses to sterilize delicate biomaterials without the damage caused by gamma irradiation, heat, or ethylene oxide gas. Karamedica creates innovative medical devices and drug delivery systems based on chitosan for medical and veterinary applications, including use as a hemostatic agent, immune adjuvant, tissue scaffold, and drug delivery vehicle.
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Karamedica, INC | Raleigh | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.